ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,889Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 1006

$1.63M Total Retail Price of All Prescriptions

Rank: 11 out of 1006

331 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 5,897 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$150 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 401 258 1 2
NEXIUM 398 218 2 28
METFORMIN HCL 301 179 3 10
AMLODIPINE BESYLATE 271 216 4 4
LISINOPRIL 248 121 5 3
ATORVASTATIN CALCIUM 243 143 6 5
ZOLPIDEM TARTRATE 234 117 7 14
LEVEMIR FLEXPEN 208 127 8 173
CRESTOR 200 124 9 18
SIMVASTATIN 198 110 10 1
HYDROCHLOROTHIAZIDE 194 124 11 11
TRAMADOL HCL 180 88 12 35
BYSTOLIC 176 84 13 84
DIOVAN 167 127 14 16
FUROSEMIDE 153 122 15 6
SINGULAIR 150 85 16 82
VENTOLIN HFA 146 73 17 161
OMEPRAZOLE 125 97 18 9
KALETRA 124 0 19 302
ATRIPLA 120 0 20 277
DIOVAN HCT 119 105 21 60
CLOTRIMAZOLE-BETAMETHASONE 118 46 22 111
MONTELUKAST SODIUM 111 64 23 125
IBUPROFEN 107 24 24 114
MELOXICAM 107 61 24 67
PROAIR HFA 106 45 26 64
TRUVADA 104 0 27 238
NOVOLOG FLEXPEN 103 38 28 190
CLOPIDOGREL 101 63 29 46
PANTOPRAZOLE SODIUM 93 40 30 32
METOPROLOL TARTRATE 92 52 31 7
CYCLOBENZAPRINE HCL 90 12 R 32 113
AZITHROMYCIN 90 31 32 39
SEROQUEL XR 88 24 34 239
SYMBICORT 88 55 34 147
METOPROLOL SUCCINATE 88 76 34 12
EXFORGE 84 59 37 232
SERTRALINE HCL 75 41 38 19
AMLODIPINE BESYLATE-BENAZEPRIL 73 50 39 77
NORVIR 71 0 40 252
GLIMEPIRIDE 70 48 41 50
LIPITOR 70 49 41 47
JANUMET 69 28 43 151
DEXILANT 69 32 43 142
NASONEX 68 18 45 176
ACTONEL 68 64 45 152
AMMONIUM LACTATE 65 36 47 337
GABAPENTIN 64 46 48 20
EPZICOM 64 0 48 340
CYMBALTA 64 40 48 41
AVODART 63 63 51 209
PLAVIX 60 47 52 61
GLIPIZIDE 59 37 53 69
MECLIZINE HCL 56 41 54 137
DONEPEZIL HCL 54 52 55 17
KETOCONAZOLE 52 30 56 206
NAPROXEN 52 18 56 121
WARFARIN SODIUM 51 40 58 8
FLUCONAZOLE 50 23 59 287
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.